New combination of drugs works together to reduce lung tumors in mice
A new study has revealed FDA-approved trametinib and entinostat (which is currently in clinical trials) can be given in tandem to produce fewer and smaller tumors in mice with LKB1-mutated non-small cell lung cancer.
Materials provided by Salk Institute. Note: Content may be edited for style and length.
Source link aaaaa